Immunotherapy in Focus: The Growing UK Keytruda Market

Ajouter une nouvelle offre d'emploi Health

2026-09-25 06:59:33 - Traduire -

Keytruda (pembrolizumab) has transformed cancer treatment in the UK, offering a powerful immunotherapy option for patients with melanoma, lung cancer, Hodgkin lymphoma, stomach cancer, and urothelial carcinoma. By harnessing the immune system to attack cancer cells, Keytruda has improved survival rates and quality of life for many patients. As the incidence of cancer rises and immunotherapy...

0 Commentaires 0 Parts 5 Vue 0 Aperçu